ECB: The appropriate monetary policy stance will be determined by data dependence and successive meetings. Inflation prospect, core inflation and its transmission will determine the interest rate path.The legal representative of Sanzhiyang Culture Media Co., Ltd. changed. Tianyancha App showed that on December 10, Hefei Sanzhiyang Culture Media Co., Ltd. changed its business. Ba Shuai stepped down as the legal representative, executive director and general manager, and Zhang Yong was the legal representative, director and manager. The company was established in May 2022 with a registered capital of RMB 1 million. Its business scope includes radio and television program production and operation, performance brokerage, advertising, organization of cultural and artistic exchange activities, conference and exhibition services, etc. It is wholly owned by Hefei Sanzhiyang Network Technology Co., Ltd.Tianyu Bio staged the "Heaven and Earth" market in the afternoon, with a turnover of over 900 million yuan.
Guan Qingyou: I am optimistic about the stock market by cutting interest rates and lowering the RRR. For example, Guan Qingyou, president and chief economist of the Financial Research Institute, said that lowering the RRR and raising interest rates will definitely happen, and from the downward trend of previous interest rates, it should be faster. Regarding the current market conditions, Guan Qingyou said that different subjects have different judgments on the market trend in one or two trading days, but he is still optimistic, and said that the positive impact of the current policy change on the capital market cannot be underestimated. Combining industrial structure and policy orientation, Guan Qingyou said that consumer companies, technology companies, and mergers and acquisitions involving the transformation and upgrading of traditional industries to emerging formats are all his optimistic directions. In addition, for the economic growth target in 2025, Guan Qingyou believes that "the target of 5% can still be contested". He also said that 2025 will be better than 2024. "In 2025, the adjustment of policies will bring more increments to the market and industry." (sohu finance)The latest collection price of the heavy anticancer star drug Regofibril has dropped to a minimum of more than 4 yuan per tablet. The reporter learned at the scene of the tenth batch of drug collection that the anti-tumor drug Regofibril tablets with annual sales of more than 1 billion yuan have been auctioned by this collection, and the price has almost dropped to between 4 yuan and 6 yuan, which is 90% lower than the price limit. Nanjing Zhengda Tianqing is expected to win the bid in the first round of quotation. Regofibril can treat colorectal cancer, liver cancer and other cancers. Its original research manufacturer is Bayer, which occupies almost all the market share in China. The price of this collection is about 172 yuan per tablet. (science and technology innovation board Daily)Indian Minister of Steel: Considering the growth of domestic consumption, there is no possibility of assets stranded in the future.
Traders' interest rate expectations for the European Central Bank remain stable: it is expected to cut interest rates by 127 basis points in 2025.Huadong Pharmaceutical has established a new company in Jiaxing with a registered capital of 60 million yuan. According to Tianyancha App, Huadong Pharmaceutical (Jiaxing) Co., Ltd. was recently established with Zhu Li as its legal representative and a registered capital of 60 million yuan. Its business scope includes drug wholesale, drug retail, decoction service for Chinese herbal pieces, third-class medical device operation, drug Internet information service, drug import and export, third-class medical device rental and medical device Internet information service. According to shareholder information, the company is wholly owned by Huadong Pharmaceutical (000963).COMEX silver fell 1.00% in the day and is now quoted at $32.63 per ounce.
Strategy guide 12-13
Strategy guide
12-13
Strategy guide
12-13
Strategy guide 12-13
Strategy guide
12-13
Strategy guide
12-13
Strategy guide 12-13